73/100B50.330
USD
-0.08
(-0.16%)
Pre Open·51.200USD+0.870(+1.73%)
Last updated: · Delayed 15 min
Fair value66.10Plus-24%52Price 50.3392
Q4 FY2026 · Earnings report
EPS estimate 0.77Revenue estimate 11.79B
Q4 FY2026 · Earnings report
EPS estimate 0.77Revenue estimate 11.79B
GSK price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
GSK's P/S ratio is 2.28: its market cap of 76.36B GBP over revenue of 33.47B GBP in the last twelve months.
- Today
- 2.28
- Average, 5 years
- 2.02
- Low, 5 years
- 1.41
- High, 5 years
- 2.76
P/S ratio = market cap ÷ revenue (last 12 months) = 76.36B ÷ 33.47B = 2.28
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 2.28 | 76.36B | 33.47B | |
| FY2025 | 31 Dec 2025 | 2.26 | 73.72B | 32.67B |
| FY2024 | 31 Dec 2024 | 1.76 | 55.09B | 31.38B |
| FY2023 | 31 Dec 2023 | 1.95 | 59.04B | 30.33B |
| FY2022 | 31 Dec 2022 | 1.99 | 58.48B | 29.32B |
| FY2021 | 31 Dec 2021 | 2.11 | 52.17B | 24.70B |
| FY2020 | 31 Dec 2020 | 2.20 | 53.61B | 24.35B |
| FY2019 | 31 Dec 2019 | 2.08 | 70.12B | 33.75B |
| FY2018 | 31 Dec 2018 | 1.91 | 58.87B | 30.82B |
| FY2017 | 31 Dec 2017 | 1.70 | 51.31B | 30.19B |
| FY2016 | 31 Dec 2016 | 2.17 | 60.64B | 27.89B |
| FY2015 | 31 Dec 2015 | 2.21 | 52.91B | 23.92B |
| FY2014 | 31 Dec 2014 | 2.29 | 52.75B | 23.01B |
| FY2013 | 31 Dec 2013 | 2.35 | 62.32B | 26.51B |
| FY2012 | 31 Dec 2012 | 1.99 | 52.51B | 26.43B |
| FY2011 | 31 Dec 2011 | 2.15 | 58.98B | 27.39B |
| FY2010 | 31 Dec 2010 | 1.80 | 51.09B | 28.39B |
| FY2009 | 31 Dec 2009 | 1.87 | 53.00B | 28.37B |
| FY2008 | 31 Dec 2008 | 2.17 | 52.95B | 24.35B |
| FY2007 | 31 Dec 2007 | 2.46 | 56.02B | 22.74B |
| FY2006 | 31 Dec 2006 | 2.62 | 60.83B | 23.22B |
| FY2005 | 31 Dec 2005 | 3.08 | 66.63B | 21.66B |
| FY2004 | 31 Dec 2004 | 2.83 | 56.58B | 19.98B |
| FY2003 | 31 Dec 2003 | 2.81 | 60.18B | 21.41B |
| FY2002 | 31 Dec 2002 | 2.59 | 54.97B | 21.21B |
| FY2001 | 31 Dec 2001 | 4.05 | 83.25B | 20.53B |
| FY2000 | 31 Dec 2000 | 5.02 | 90.79B | 18.08B |
| FY1999 | 31 Dec 1999 | 11.81 | 100.28B | 8.49B |
| FY1998 | 31 Dec 1998 | 15.10 | 120.56B | 7.98B |
| FY1997 | 31 Dec 1997 | 10.35 | 82.55B | 7.98B |
| FY1996 | 31 Dec 1996 | 6.26 | 52.21B | 8.34B |
| FY1995 | 31 Dec 1995 | 4.53 | 47.52B | 10.49B |
| FY1994 | 30 Jun 1995 | 5.89 | 38.18B | 6.48B |
| FY1993 | 30 Jun 1994 | 4.63 | 26.19B | 5.66B |
| FY1992 | 30 Jun 1993 | 5.55 | 27.36B | 4.93B |
| FY1991 | 30 Jun 1992 | 7.84 | 32.11B | 4.10B |
| FY1990 | 30 Jun 1991 | 9.12 | 31.00B | 3.40B |
| FY1989 | 30 Jun 1990 | 6.28 | 19.95B | 3.18B |
| FY1988 | 30 Jun 1989 | 3.22 | 8.26B | 2.57B |
| FY1987 | 30 Jun 1988 | 2.89 | 5.94B | 2.06B |
| FY1986 | 30 Jun 1987 | 5.61 | 9.77B | 1.74B |
| FY1985 | 30 Jun 1986 | 4.26 | 6.08B | 1.43B |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 2.17 | 72.79B | 33.47B |
| Q2 FY2026 | 30 Jun 2026 | 2.39 | 79.33B | 33.20B |
| Q1 FY2026 | 31 Mar 2026 | 2.56 | 83.94B | 32.78B |
| Q4 FY2025 | 31 Dec 2025 | 2.24 | 73.14B | 32.67B |
| Q3 FY2025 | 30 Sept 2025 | 2.01 | 64.73B | 32.17B |
| Q2 FY2025 | 30 Jun 2025 | 1.80 | 56.82B | 31.63B |
| Q1 FY2025 | 31 Mar 2025 | 1.94 | 61.29B | 31.53B |
| Q4 FY2024 | 31 Dec 2024 | 1.76 | 55.14B | 31.38B |
| Q3 FY2024 | 30 Sept 2024 | 1.99 | 62.34B | 31.31B |
| Q2 FY2024 | 30 Jun 2024 | 1.97 | 61.88B | 31.45B |
| Q1 FY2024 | 31 Mar 2024 | 2.24 | 68.75B | 30.74B |
| Q4 FY2023 | 31 Dec 2023 | 1.95 | 59.10B | 30.33B |
| Q3 FY2023 | 30 Sept 2023 | 2.03 | 60.25B | 29.65B |
| Q2 FY2023 | 30 Jun 2023 | 1.94 | 56.87B | 29.33B |
| Q1 FY2023 | 31 Mar 2023 | 2.01 | 58.32B | 29.09B |
| Q4 FY2022 | 31 Dec 2022 | 2.00 | 58.59B | 29.32B |
| Q3 FY2022 | 30 Sept 2022 | 1.69 | 53.10B | 31.48B |
| Q2 FY2022 | 30 Jun 2022 | 2.38 | 71.95B | 30.27B |
| Q1 FY2022 | 31 Mar 2022 | 2.28 | 66.57B | 29.18B |
| Q4 FY2021 | 31 Dec 2021 | 2.22 | 65.27B | 29.41B |
| Q3 FY2021 | 30 Sept 2021 | 1.98 | 56.79B | 28.62B |
| Q2 FY2021 | 30 Jun 2021 | 1.88 | 57.63B | 30.64B |
| Q1 FY2021 | 31 Mar 2021 | 1.59 | 51.72B | 32.43B |
| Q4 FY2020 | 31 Dec 2020 | 1.57 | 53.66B | 34.10B |
| Q3 FY2020 | 30 Sept 2020 | 1.69 | 58.03B | 34.26B |
| Q2 FY2020 | 30 Jun 2020 | 1.87 | 65.48B | 35.00B |
| Q1 FY2020 | 31 Mar 2020 | 1.72 | 60.52B | 35.18B |
| Q4 FY2019 | 31 Dec 2019 | 2.08 | 70.20B | 33.75B |
| Q3 FY2019 | 30 Sept 2019 | 2.08 | 68.76B | 33.05B |
| Q2 FY2019 | 30 Jun 2019 | 1.99 | 63.29B | 31.76B |
| Q1 FY2019 | 31 Mar 2019 | 2.02 | 63.24B | 31.26B |
| Q4 FY2018 | 31 Dec 2018 | 1.91 | 58.95B | 30.82B |
| Q3 FY2018 | 30 Sept 2018 | 2.00 | 60.43B | 30.26B |
| Q2 FY2018 | 30 Jun 2018 | 2.00 | 60.00B | 30.01B |
| Q1 FY2018 | 31 Mar 2018 | 1.82 | 54.67B | 30.02B |
| Q4 FY2017 | 31 Dec 2017 | 1.70 | 51.36B | 30.19B |
| Q3 FY2017 | 30 Sept 2017 | 1.97 | 59.27B | 30.13B |
| Q2 FY2017 | 30 Jun 2017 | 2.16 | 64.34B | 29.83B |
| Q1 FY2017 | 31 Mar 2017 | 2.26 | 65.56B | 29.04B |
| Q4 FY2016 | 31 Dec 2016 | 2.18 | 60.73B | 27.89B |
| Q3 FY2016 | 30 Sept 2016 | 2.43 | 64.67B | 26.59B |
| Q2 FY2016 | 30 Jun 2016 | 2.50 | 63.06B | 25.17B |
| Q1 FY2016 | 31 Mar 2016 | 2.23 | 54.73B | 24.53B |
| Q4 FY2015 | 31 Dec 2015 | 2.21 | 52.95B | 23.92B |
| Q3 FY2015 | 30 Sept 2015 | 2.06 | 49.16B | 23.82B |
| Q2 FY2015 | 30 Jun 2015 | 2.19 | 51.23B | 23.34B |
| Q1 FY2015 | 31 Mar 2015 | 2.61 | 59.99B | 23.02B |
| Q4 FY2014 | 31 Dec 2014 | 2.29 | 52.76B | 23.01B |
| Q3 FY2014 | 30 Sept 2014 | 2.30 | 54.49B | 23.73B |
| Q2 FY2014 | 30 Jun 2014 | 2.45 | 60.14B | 24.59B |
| Q1 FY2014 | 31 Mar 2014 | 2.40 | 61.57B | 25.65B |
| Q4 FY2013 | 31 Dec 2013 | 2.34 | 61.89B | 26.51B |
| Q3 FY2013 | 30 Sept 2013 | 2.27 | 59.95B | 26.40B |
| Q2 FY2013 | 30 Jun 2013 | 2.43 | 64.10B | 26.42B |
| Q1 FY2013 | 31 Mar 2013 | 2.27 | 59.66B | 26.26B |
| Q4 FY2012 | 31 Dec 2012 | 1.96 | 51.77B | 26.43B |
| Q3 FY2012 | 30 Sept 2012 | 2.12 | 56.31B | 26.61B |
| Q2 FY2012 | 30 Jun 2012 | 2.11 | 57.39B | 27.18B |
| Q1 FY2012 | 31 Mar 2012 | 2.03 | 55.65B | 27.44B |
| Q4 FY2011 | 31 Dec 2011 | 2.13 | 58.21B | 27.39B |
| Q3 FY2011 | 30 Sept 2011 | 1.92 | 52.98B | 27.61B |
| Q2 FY2011 | 30 Jun 2011 | 1.98 | 54.15B | 27.32B |
| Q1 FY2011 | 31 Mar 2011 | 1.76 | 48.71B | 27.62B |
| Q4 FY2010 | 31 Dec 2010 | 1.80 | 51.10B | 28.39B |
| Q3 FY2010 | 30 Sept 2010 | 1.75 | 51.16B | 29.29B |
| Q2 FY2010 | 30 Jun 2010 | 1.58 | 46.29B | 29.23B |
| Q1 FY2010 | 31 Mar 2010 | 1.78 | 51.51B | 28.96B |
| Q4 FY2009 | 31 Dec 2009 | 1.87 | 53.01B | 28.37B |
| Q3 FY2009 | 30 Sept 2009 | 1.84 | 50.03B | 27.18B |
| Q2 FY2009 | 30 Jun 2009 | 1.65 | 43.49B | 26.31B |
| Q1 FY2009 | 31 Mar 2009 | 1.73 | 43.91B | 25.44B |
| Q4 FY2008 | 31 Dec 2008 | 2.13 | 51.76B | 24.35B |
| Q3 FY2008 | 30 Sept 2008 | 2.13 | 49.84B | 23.44B |
| Q2 FY2008 | 30 Jun 2008 | 2.02 | 46.43B | 23.03B |
| Q1 FY2008 | 31 Mar 2008 | 2.01 | 45.81B | 22.83B |
| Q4 FY2007 | 31 Dec 2007 | 2.38 | 54.10B | 22.74B |
| Q3 FY2007 | 30 Sept 2007 | 2.57 | 58.37B | 22.69B |
| Q2 FY2007 | 30 Jun 2007 | 2.54 | 58.11B | 22.86B |
| Q1 FY2007 | 31 Mar 2007 | 2.73 | 62.87B | 23.00B |
| Q4 FY2006 | 31 Dec 2006 | 2.60 | 60.31B | 23.21B |
| Q3 FY2006 | 30 Sept 2006 | 2.77 | 64.10B | 23.16B |
| Q2 FY2006 | 30 Jun 2006 | 2.97 | 68.27B | 22.99B |
| Q1 FY2006 | 31 Mar 2006 | 3.04 | 68.11B | 22.42B |
| Q4 FY2005 | 31 Dec 2005 | 3.06 | 66.27B | 21.65B |
| Q3 FY2005 | 30 Sept 2005 | 3.08 | 65.73B | 21.35B |
| Q2 FY2005 | 30 Jun 2005 | 2.96 | 61.51B | 20.80B |
| Q1 FY2005 | 31 Mar 2005 | 2.69 | 55.32B | 20.53B |
| Q4 FY2004 | 31 Dec 2004 | 2.78 | 56.55B | 20.35B |
| Q3 FY2004 | 30 Sept 2004 | 2.75 | 55.24B | 20.10B |
| Q2 FY2004 | 30 Jun 2004 | 2.53 | 52.33B | 20.64B |
| Q1 FY2004 | 31 Mar 2004 | 2.38 | 49.94B | 20.99B |
| Q4 FY2003 | 31 Dec 2003 | 2.75 | 58.83B | 21.41B |
| Q3 FY2003 | 30 Sept 2003 | 2.71 | 58.86B | 21.73B |
| Q2 FY2003 | 30 Jun 2003 | 2.68 | 56.97B | 21.28B |
| Q1 FY2003 | 31 Mar 2003 | 2.43 | 51.94B | 21.38B |
| Q4 FY2002 | 31 Dec 2002 | 2.56 | 54.28B | 21.21B |
| Q3 FY2002 | 30 Sept 2002 | 2.70 | 57.22B | 21.21B |
| Q2 FY2002 | 30 Jun 2002 | 3.10 | 65.73B | 21.18B |
| Q1 FY2002 | 31 Mar 2002 | 3.77 | 78.76B | 20.89B |
| Q4 FY2001 | 31 Dec 2001 | 3.99 | 82.00B | 20.53B |
| Q3 FY2001 | 30 Sept 2001 | 4.55 | 90.56B | 19.90B |
| Q2 FY2001 | 30 Jun 2001 | 4.98 | 96.30B | 19.34B |
| Q1 FY2001 | 31 Mar 2001 | 4.79 | 89.72B | 18.75B |
| Q4 FY2000 | 31 Dec 2000 | 5.02 | 90.82B | 18.08B |
| Q3 FY2000 | 30 Sept 2000 | 6.48 | 99.34B | 15.33B |
| Q2 FY2000 | 30 Jun 2000 | 7.00 | 92.24B | 13.18B |
| Q1 FY2000 | 31 Mar 2000 | 8.13 | 87.47B | 10.75B |
| Q4 FY1999 | 31 Dec 1999 | 11.48 | 99.56B | 8.68B |
| Q3 FY1999 | 30 Sept 1999 | 10.73 | 90.81B | 8.46B |
| Q2 FY1999 | 30 Jun 1999 | 12.51 | 103.11B | 8.24B |
| Q1 FY1999 | 31 Mar 1999 | 14.78 | 119.24B | 8.06B |
| Q4 FY1998 | 31 Dec 1998 | 15.00 | 119.73B | 7.98B |
| Q3 FY1998 | 30 Sept 1998 | 12.36 | 95.91B | 7.76B |
| Q2 FY1998 | 30 Jun 1998 | 13.51 | 104.09B | 7.71B |
| Q1 FY1998 | 31 Mar 1998 | 12.10 | 94.19B | 7.79B |
| Q4 FY1997 | 31 Dec 1997 | 10.45 | 82.54B | 7.90B |
| Q3 FY1997 | 30 Sept 1997 | 8.39 | 79.10B | 9.42B |
| Q2 FY1997 | 30 Jun 1997 | 7.19 | 71.25B | 9.91B |
| Q1 FY1997 | 31 Mar 1997 | 6.14 | 61.33B | 9.99B |
| Q4 FY1996 | 31 Dec 1996 | 5.15 | 51.87B | 10.07B |
| Q3 FY1996 | 30 Sept 1996 | — | 58.07B | — |
| Q2 FY1996 | 30 Jun 1996 | — | 49.00B | — |
| Q1 FY1996 | 31 Mar 1996 | — | 45.70B | — |
| Q3 FY1995 | 30 Sept 1995 | 5.91 | 38.78B | 6.56B |
| Q2 FY1995 | 30 Jun 1995 | 5.70 | 37.44B | 6.57B |
| Q1 FY1995 | 31 Mar 1995 | 5.80 | 35.93B | 6.19B |
| Q4 FY1994 | 31 Dec 1994 | 5.42 | 33.17B | 6.12B |
| Q3 FY1994 | 30 Sept 1994 | 5.00 | 29.46B | 5.89B |
| Q2 FY1994 | 30 Jun 1994 | 4.60 | 26.00B | 5.65B |
| Q1 FY1994 | 31 Mar 1994 | 5.41 | 29.37B | 5.43B |
| Q4 FY1993 | 31 Dec 1993 | 6.36 | 34.48B | 5.42B |
| Q3 FY1993 | 30 Sept 1993 | 6.02 | 30.96B | 5.14B |
| Q2 FY1993 | 30 Jun 1993 | 5.58 | 26.38B | 4.73B |
| Q1 FY1993 | 31 Mar 1993 | 6.73 | 29.41B | 4.37B |
| Q4 FY1992 | 31 Dec 1992 | 9.69 | 38.57B | 3.98B |
| Q3 FY1992 | 30 Sept 1992 | 9.66 | 37.42B | 3.88B |
| Q2 FY1992 | 30 Jun 1992 | 7.93 | 31.78B | 4.01B |
| Q1 FY1992 | 31 Mar 1992 | 8.68 | 37.25B | 4.29B |
| Q4 FY1991 | 31 Dec 1991 | 10.22 | 40.50B | 3.96B |
| Q3 FY1991 | 30 Sept 1991 | 9.19 | 33.43B | 3.64B |
| Q2 FY1991 | 30 Jun 1991 | 9.51 | 31.00B | 3.26B |
| Q1 FY1991 | 31 Mar 1991 | 8.61 | 27.27B | 3.17B |
| Q4 FY1990 | 31 Dec 1990 | 8.03 | 25.38B | 3.16B |
| Q3 FY1990 | 30 Sept 1990 | 5.94 | 18.98B | 3.20B |
| Q2 FY1990 | 30 Jun 1990 | 6.20 | 19.88B | 3.20B |
| Q1 FY1990 | 31 Mar 1990 | 6.10 | 18.71B | 3.07B |
| Q4 FY1989 | 31 Dec 1989 | 4.16 | 11.94B | 2.87B |
| Q3 FY1989 | 30 Sept 1989 | 3.37 | 9.02B | 2.68B |
| Q2 FY1989 | 30 Jun 1989 | 3.26 | 8.26B | 2.53B |
| Q1 FY1989 | 31 Mar 1989 | 3.29 | 7.87B | 2.39B |
| Q4 FY1988 | 31 Dec 1988 | 3.45 | 7.89B | 2.29B |
| Q3 FY1988 | 30 Sept 1988 | 2.97 | 6.50B | 2.19B |
| Q2 FY1988 | 30 Jun 1988 | 2.80 | 5.94B | 2.12B |
| Q1 FY1988 | 31 Mar 1988 | 2.98 | 5.77B | 1.94B |
| Q4 FY1987 | 31 Dec 1987 | 3.73 | 7.16B | 1.92B |
| Q3 FY1987 | 30 Sept 1987 | 5.59 | 10.63B | 1.90B |
| Q2 FY1987 | 30 Jun 1987 | 5.37 | 9.77B | 1.82B |
| Q1 FY1987 | 31 Mar 1987 | 5.20 | 8.63B | 1.66B |
| Q4 FY1986 | 31 Dec 1986 | 4.88 | 7.68B | 1.57B |
| Q3 FY1986 | 30 Sept 1986 | 3.65 | 5.52B | 1.51B |
| Q2 FY1986 | 30 Jun 1986 | 4.19 | 6.08B | 1.45B |
| Q1 FY1986 | 31 Mar 1986 | — | 6.39B | — |
| Q4 FY1985 | 31 Dec 1985 | — | 5.67B | — |
| Q3 FY1985 | 30 Sept 1985 | — | 4.74B | — |
Figures in GBP. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about GSK's P/S ratio
Source: Financial Modeling Prep